Paper Details

  1. Home
  2. Paper Details

Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study.

Author: KanokrungseeSilada, PruettivorawongseDuangrat, RajatanavinNatta

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigated the efficacy and safety of bimatoprost ophthalmic solution compared to tacrolimus ointment for treating nonsegmental facial vitiligo. Both treatments showed significant improvement in vitiligo surface area and repigmentation, with comparable results. Bimatoprost was found to be safe and can be considered an alternative treatment option for facial vitiligo.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Vitiligo is a common acquired pigmentary disorder. Bimatoprost ophthalmic solution was indicated in the treatment of open-angle glaucoma and eyebrow hypotrichosis. However, lid hyperpigmentation was reported as a complication. OBJECTIVE: To study the efficacy and safety of 0.01% bimatop...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/jocd.13648

データ提供：米国国立医学図書館（NLM）

Bimatoprost: A Promising Treatment Option for Facial Vitiligo

Vitiligo, a common skin condition characterized by depigmentation, can be challenging to treat. This research investigates the efficacy and safety of topical bimatoprost, a medication commonly used for glaucoma and eyebrow hypotrichosis, as a treatment for nonsegmental facial vitiligo. The study compares the effectiveness of bimatoprost with tacrolimus ointment in a group of patients with facial vitiligo.

Bimatoprost: A Potential Oasis in the Desert of Vitiligo Treatment

This study offers a new perspective on the treatment of facial vitiligo, suggesting that bimatoprost, a medication previously used for other conditions, could be a viable option. The researchers found that topical bimatoprost demonstrated comparable efficacy to tacrolimus ointment in promoting repigmentation in patients with nonsegmental facial vitiligo. This finding provides a potential alternative treatment option for patients seeking repigmentation.

Vitiligo Treatment: Exploring New Horizons

This study highlights the importance of exploring new therapeutic approaches for treating vitiligo. The researchers' findings suggest that bimatoprost, a medication already used for other conditions, could offer a valuable addition to the treatment arsenal for facial vitiligo. This research encourages further investigation of bimatoprost as a potential treatment for this challenging skin condition.

Dr.Camel's Conclusion

This study is like discovering a hidden oasis in the vast desert of vitiligo treatment. The researchers' findings suggest that bimatoprost, a medication previously used for other conditions, could offer a promising new avenue for treating facial vitiligo. This research encourages further exploration of bimatoprost as a potential treatment option, offering hope for patients seeking repigmentation and improved quality of life.

Date :
  1. Date Completed 2021-05-14
  2. Date Revised 2022-05-31
Further Info :

Pubmed ID

32744369

DOI: Digital Object Identifier

10.1111/jocd.13648

Related Literature

Article Analysis
・Effects of bimatoprost ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.